RT Journal Article
SR Electronic
T1 Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002128
DO 10.1136/jitc-2020-002128
VO 9
IS 3
A1 Lee, Maxwell Y
A1 Robbins, Yvette
A1 Sievers, Cem
A1 Friedman, Jay
A1 Abdul Sater, Houssein
A1 Clavijo, Paul E
A1 Judd, Nancy
A1 Tsong, Edward
A1 Silvin, Chris
A1 Soon-Shiong, Patrick
A1 Padget, Michelle R
A1 Schlom, Jeffrey
A1 Hodge, James
A1 Hinrichs, Christian
A1 Allen, Clint
YR 2021
UL http://jitc.bmj.com/content/9/3/e002128.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.